Carlos Salama

2.2k citations
12 papers · 862 indexed · 1 hit paper · h-index 7

Carlos Salama

12 papers receiving 840 citations

Hit Papers

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia7982020202620222024250500750

Peers

Carlos Salama
Comparison fields: 5 of 98
  • Infectious Diseases 656
  • Neurology 426
  • Critical Care and Intensive Care Medicine 56
  • Applied Microbiology and Biotechnology 12
  • Obstetrics and Gynecology 33
Replace Beverly Assman with:
Beverly Assman United States
Qianchuan Huang China
Luisa Marchioni Italy
Benjamin T. Bradley United States
Amaylia Oehadian Indonesia
Qingfeng Shi China
Emma J. Kooistra Netherlands
Lianfeng Lu China
Carlos Salama relative to Beverly Assman United States Beverly Assman's profile →
Citations per field
00.5×1.5×
Beverly Assman · 1×
Citations per year

Countries citing papers authored by Carlos Salama

Since Specialization
Citations

This map shows the geographic impact of Carlos Salama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Salama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Salama more than expected).

Fields of papers citing papers by Carlos Salama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Salama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Salama. The network helps show where Carlos Salama may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carlos Salama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carlos Salama Line = papers co-authored together Carlos Salama links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 20222
2 20217
3 20215
4 20212
5 202011
6 20207
7
Tocilizumab in Patients Hospitalized with Covid-19 Pneumoniabreakdown →
2020798
8 20191
9 20153
10 20057
11 20048
12 200311

About Carlos Salama

Carlos Salama is a scholar working on Infectious Diseases, Periodontics and Virology, having authored 12 papers that have together received 862 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Fungal Infections and Studies (3 papers), Long-Term Effects of COVID-19 (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Diabetes and associated disorders (2 papers), Nuclear Structure and Function (1 paper), Viral Infections and Immunology Research (1 paper) and HIV Research and Treatment (1 paper). The work is most often cited by research in Infectious Diseases (656 citations), Neurology (426 citations) and Critical Care and Intensive Care Medicine (56 citations). Carlos Salama has collaborated with scholars based in United States, Switzerland and Ireland. Frequent co-authors include Emma Kaplan‐Lewis, William Reiss, Benjamin Krämer, Reena Shah, Shalini Mohan, Jamie Freedman, Jeffrey D. Neidhart, Julia Garcia‐Diaz, Miriam L. Cameron and Jian Han. Their work appears in journals such as New England Journal of Medicine, Clinical Infectious Diseases and AIDS Patient Care and STDs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026